In this conversation, Dr. Robert Redfield discusses recent advances in Alzheimer’s detection and treatment, including a new blood test, earlier diagnosis, and the importance of proactive screening for adults over 50.

Video highlights

• Dr. Robert Redfield explains how Alzheimer’s is becoming more detectable and treatable than it used to be.
• He points to a new FDA-approved blood test that can help identify early signs of Alzheimer’s before clinical symptoms appear.
• He discusses the idea that Alzheimer’s has distinct stages, including preclinical stages that can be caught earlier.
• Redfield advocates for proactive screening, suggesting adults over 50 consider annual testing.
• He also notes that both FDA-approved treatments and lifestyle changes may help slow disease progression.
• The conversation touches on the personal and economic burden of Alzheimer’s for patients and caregivers.